Pharmacokinetics of gabapentin in horses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 2, 2008, Pages 175-177

  Dirikolu, L ^a,b   Dafalla, A ^c   Ely, K J ^c   Connerly, A L ^c   Jones, C N ^c   ElkHoly, H ^c   Lehner, A F ^d   Thompson, K ^c   Tobin, T ^d  

^a MC 002 ^*  (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c TUSKEGEE UNIVERSITY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HORSE; MARE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; AMINES; ANIMALS; ANTICONVULSANTS; AREA UNDER CURVE; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HORSES;

EQUIDAE;

EID: 40149092981     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00943.x     Document Type: Article

References (22)

1. ARCI (2004) Uniform Classification Guidelines for Foreign Substances and Recommended Penalties and Model Rule. Association of Racing Commissioners International, Lexington, KY. Available at: http://www.arci.com/druglisting.pdf ; accessed on April 2007.
2. Bahrami, G. Mohammadi, B. (2006) Sensitive microanalysis of gabapentin by high-performance liquid chromatography in human serum using pre-column derivatization with 4-chloro-7-nitrobenzofurazan: application to a bioequivalence study. Journal of Chromatography. Part B, Analytical Technologies in the Biomedical and Life Sciences, 837, 24 28.
3. Berry, D.J., Beran, R.G., Plunkeft, M.J., Clarke, L.A. Hung, W.T. (2003) The absorption of gabapentin following high dose calculation. Seizure, 12, 28 36.
4. Chadwick, D. (1994) Drug profile: gabapentin. The Lancet, 343, 89 91.
5. Gambelunghe, C., Mariucci, G., Tantucci, M. Ambrosini, V. (2005) Chromatography-tandem mass spectrometry analysis of gabapentin in serum. Journal of Chromatography, 19, 63 67.
6. Goa, K.L. Sorkin, E.M. (1993) Gabapentin, a review of its pharmacological properties and clinical potential in epilepsy. Drugs, 46, 409 427.
7. Govendir, M., Perkins, M. Malik, R. (2005) Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent. Australian Veterinary Journal, 83, 602 608.
8. Haig, G.M., Bockbrader, H.N., Wesche, D.L., Boellner, S.W., Ouellet, D., Brown, R.R., Randinitis, E.J. Posvar, E.L. (2001) Single-dose gabapentin pharmacokinetics and safety in infants and children. Journal of Clinical Pharmacology, 41, 507 514.
9. Hengy, H. Kölle, E.U. (1985) Determination of gabapentin in plasma and urine by high-performance liquid chromatography and pre-column labelling for ultraviolet detection. Journal of Chromatography, 341, 473 478.
10. Lehner, A.F., Stewart, B., Dafalla, A., Ely, K.J., Connerly, A.L., Jones, C.N., ElkHoly, H., Lehner, A.F., Thompson, K., Tobin, T. Dirikolu, L. (2007) Gabapentin in horses: validation of an analytical method for quantitation. Journal of Analytical Toxicology, 31, 555 565.
11. Matar, K.M., Nicholls, P.J., Bawazir, S.A., Al-Hassan, M.I. Tekle, A. (2000) Effect of vigabatrin and gabapentin on phenytoin pharmacokinetics in the dog. Pharmacological Research, 42, 517 521.
12. Mclean, M.J. (1995) Gabapentin. Epilepsia, 36 (Suppl. 2 S72 S86.
13. Platt, S.R., Adams, V., Garosi, L.S., Abramson, C.J., Penderis, J., De Stefani, A. Matiasek, L. (2006) Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy. Veterinary Record, 159, 881 884.
14. Radulovic, L.L., Turck, D., Von Hodenberg, A., Vollmer, K.O., Mcnally, W.P., Dehart, P.D., Hanson, B.J., Bockbrader, H.N. Chang, T. (1995) Disposition of gabapentin (Neurontin) in mice, rats, dogs, and monkeys. Drug Metabolism and Disposition, 23, 441 448.
15. Stefan, H. Feuerstein, T.J. (2007) Novel anticonvulsant drugs. Pharmacology & Therapeutics, 113, 165 183.
16. Stevenson, C.M., Kim, J. Fleisher, D. (1997a) Colonic absorption of antiepileptic agents. Epilepsia, 38, 63 67.
17. Stevenson, C.M., Radulovic, L.L., Bockbrader, H.N. Fleisher, D. (1997b) Contrasting nutrient effects on the plasma levels of an amino acid-like antiepileptic agent from jejunal administration in dogs. Journal of Pharmaceutical Sciences, 86, 953 957.
18. Taylor, C. (1994) Emerging perspectives on the mechanism of action of gabapentin. Neurology, 44, S10 S16.
19. Vollmer, K.O., Von Hodenberg, A. Kolle, E.U. (1986) Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittel-Forschung, 36, 830 839.
20. Wolf, C.E., Saady, J.J. Poklis, A. (1996) Determination of gabapentin in serum using solid-phase extraction and gas-liquid chromatography. Journal of Analytical Toxicology, 20, 498 501.
21. Yamaoka, K., Nakaqawa, T. Uno, T. (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165 175.
22. Zhu, Z. Neirinck, L. (2002) High-performance liquid chromatographic method for the determination of gabapentin in human plasma. Journal of Chromatography. Part B, Analytical Technologies in the Biomedical and Life Sciences, 779, 307 312.